Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
25 05 2022
Historique:
pubmed: 28 4 2022
medline: 28 5 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

There is increasing evidence for the importance of human leukocyte antigen C (HLA-C)-restricted CD8

Identifiants

pubmed: 35475667
doi: 10.1128/jvi.00432-22
pmc: PMC9131871
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0
HLA-C Antigens 0
Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0043222

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI118549
Pays : United States
Organisme : HHS | National Institutes of Health (NIH)
ID : R01 AI 118549
Organisme : UKRI | Medical Research Council (MRC)
ID : MR/K012037

Références

Eur J Immunol. 1988 May;18(5):801-10
pubmed: 2967765
Nature. 2000 Jun 1;405(6786):537-43
pubmed: 10850706
Cell Rep. 2016 Jun 7;15(10):2279-2291
pubmed: 27239036
J Virol. 2018 Feb 12;92(5):
pubmed: 29237835
Leukemia. 2015 Mar;29(3):647-59
pubmed: 25092142
J Virol. 2012 Oct;86(19):10870-2
pubmed: 22811530
Curr Protoc Immunol. 2010 Feb;Chapter 18:Unit 18.17
pubmed: 20143317
Open AIDS J. 2012;6:274-88
pubmed: 23289052
Nat Commun. 2016 Nov 21;7:13404
pubmed: 27869121
J Virol. 2014 May;88(9):4764-75
pubmed: 24522911
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W281-7
pubmed: 22638583
J Virol. 2006 Oct;80(19):9779-88
pubmed: 16973582
PLoS One. 2021 Jun 2;16(6):e0252198
pubmed: 34077451
AIDS. 2021 Jan 1;35(1):33-43
pubmed: 33031103
J Infect Dis. 2020 Jan 14;221(3):474-482
pubmed: 31560392
AIDS. 1999 Oct 1;13(14):1990-1
pubmed: 10513667
J Infect Dis. 2017 Dec 12;216(11):1415-1424
pubmed: 28968792
Front Genet. 2021 Aug 26;12:720213
pubmed: 34512729
Methods. 2003 Mar;29(3):289-98
pubmed: 12725794
J Virol. 2010 Mar;84(5):2610-7
pubmed: 20032191
Cell Rep. 2021 Jul 13;36(2):109378
pubmed: 34260940
Immunity. 2012 Sep 21;37(3):426-40
pubmed: 22999948
Brief Bioinform. 2020 Jul 15;21(4):1119-1135
pubmed: 31204427
Hum Vaccin Immunother. 2014;10(12):3531-43
pubmed: 25668665
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14
pubmed: 10694578
Curr Opin Immunol. 2016 Aug;41:9-17
pubmed: 27155075
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24748-24759
pubmed: 31748275
J Virol. 2014 Nov;88(22):12992-3004
pubmed: 25165114
J Virol. 2014 Nov;88(22):12937-48
pubmed: 25165115
Hum Immunol. 1997 Sep 15;57(1):1-18
pubmed: 9438190
Cell. 2021 Jul 22;184(15):3962-3980.e17
pubmed: 34171305
PLoS One. 2012;7(7):e41703
pubmed: 22848572
Science. 2007 Aug 17;317(5840):944-7
pubmed: 17641165
Cell Rep. 2016 Nov 22;17(9):2210-2220
pubmed: 27880898
Eur J Immunol. 1977 Aug;7(8):580-5
pubmed: 332508
Science. 2013 Apr 5;340(6128):87-91
pubmed: 23559252
J Immunol. 2015 Apr 15;194(8):3594-600
pubmed: 25754738
J Virol. 2010 Oct;84(19):9879-88
pubmed: 20660184
Trends Mol Med. 2001 Sep;7(9):379-81
pubmed: 11530315
Front Immunol. 2018 Apr 27;9:912
pubmed: 29780384
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2981-6
pubmed: 18299564
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
J Immunol Methods. 2013 May 31;391(1-2):174-8
pubmed: 23500782
Immunogenetics. 2015 Aug;67(8):425-36
pubmed: 26040913
Proteomics. 2021 Sep;21(17-18):e2100142
pubmed: 34275180
J Virol. 2019 Aug 13;93(17):
pubmed: 31217245
PLoS One. 2013 Jun 10;8(6):e66298
pubmed: 23762485
AIDS. 2003 Dec 5;17(18):2581-91
pubmed: 14685052

Auteurs

Takayuki Chikata (T)

Tokyo Laboratory and Division of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.

Wayne Paes (W)

Nuffield Department of Clinical Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.

Nozomi Kuse (N)

Tokyo Laboratory and Division of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.

Thomas Partridge (T)

Nuffield Department of Clinical Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.

Hiroyuki Gatanaga (H)

Tokyo Laboratory and Division of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.

Yu Zhang (Y)

Tokyo Laboratory and Division of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.

Kimiko Kuroki (K)

Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido Universitygrid.39158.36, Sapporo, Japan.

Katsumi Maenaka (K)

Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido Universitygrid.39158.36, Sapporo, Japan.

Nicola Ternette (N)

Nuffield Department of Clinical Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.

Shinichi Oka (S)

Tokyo Laboratory and Division of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.

Persephone Borrow (P)

Nuffield Department of Clinical Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.

Masafumi Takiguchi (M)

Tokyo Laboratory and Division of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto Universitygrid.274841.c, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH